Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7522729 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7515147 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL2877290 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL5812678 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL9773213 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7519047 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL6049889 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL1683717 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7522764 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7517294 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132660-A1 | METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION | L'OREAL (FR) | 2025-06-26 | — | — | WO | disclosed |
| CN-119343126-A | Skin barrier protection delivery system and method thereof | 宝宝实验室公司 | 2025-01-21 | — | — | CN | disclosed |
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-09 | — | — | US | disclosed |
| WO-2025006991-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-02 | — | — | WO | disclosed |
| WO-2023205439-A2 | SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF | BOBO LABS INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2022266493-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2022-12-22 | — | — | WO | disclosed |
| US-20200261580-A1 | Photodynamic Therapy Method for Skin Disorders | DUSA PHARMACEUTICALS, INC. | 2020-08-20 | — | — | US | disclosed |
| EP-3655035-A1 | PHOTODYNAMIC THERAPY METHOD FOR SKIN DISORDERS | Willey, Andrea (US) | 2020-05-27 | — | — | EP | disclosed |
| WO-2019018408-A1 | PHOTODYNAMIC THERAPY METHOD FOR SKIN DISORDERS | WILLEY ANDREA (US) | 2019-01-24 | — | — | WO | disclosed |
| WO-2001002028-A2 | PRE-FORMED, SHEET DEVICES SUITABLE FOR TOPICAL APPLICATION | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001001951-A1 | SHEET-LIKE DEVICES | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001001952-A1 | DEVICES | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| CN-1277548-A | Cleansing and conditioning article for skin or hair | PROCTER & GAMBLE (US) | 2000-12-20 | — | — | CN | disclosed |
| US-6153208-A | A WATER INSOLUBLE SUBSTRATE HAVING A SEPARATE CLEANSING AND CONDITIONING PORTIONS WITH DIFFERENT WET EXTENSIBLE, A LATHERING SURFACTANT; DRY WASHCLOTH | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-28 | — | — | US | disclosed |
| EP-1011630-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999055303-A1 | CLEANSING ARTICLES FOR SKIN AND/OR HAIR WHICH ALSO DEPOSITS SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999013861-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |
| US-5831125-A | Method of making primary amide derivative | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-11-03 | — | — | US | disclosed |
| EP-0835864-A2 | A method of preparing primary amide derivatives | Takasago International Corporation (JP) | 1998-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | EBP, ADH1A, ADH1C | GPR84 205/4885FFAR1 234/4885ZDHHC7 1572/4885 |
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | RBP4, RARA, RARB | GPR84 481/4885FFAR1 449/4885ZDHHC7 398/4885 |
| US-20200261580-A1 | Photodynamic Therapy Method for Skin Disorders | ALAD, KRT18, DHPS | GPR84 3135/4885FFAR1 3327/4885ZDHHC7 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.